Spacer
PedifixBannerAS3_319
Spacer
LaserToeCU1119
Spacer
PMbannerE7-913.jpg
MDBuyingGroupFX220
Podiatry Management Online


Facebook

Podiatry Management Online
Podiatry Management Online


AllardBannerGY320

Search

 
Search Results Details
Back To List Of Search Results

07/02/2019    

RESPONSES/COMMENTS (NON-CLINICAL) - PART 2B



From: Peter Bellezza, DPM


 



If there are podiatry residents out there thinking of committing suicide, then they probably should NOT have been accepted to podiatry school and pushed through, by school administration, to graduate in the first place. There is nothing stressful about podiatry residency training when you compare it to being an internal medicine resident, general surgery resident, orthopedic resident, etc. 


 


The stakes are higher in those training programs. They just are. Intern residents from these specialty tracks are dealing with patients with more diverse pathology. Intern residents in these specialty tracks are actually medically managing these patients, dealing with complications during inpatient care. Things that most podiatry residents don't have to deal with... 


 


Editor's note: Dr. Bellezza's extended-length letter can be read here.


Other messages in this thread:


09/10/2020    

RESPONSES/COMMENTS (NON-CLINICAL) - PART 2B



From: Ben Cullen, DPM


 


I respectfully disagree with Dr. Gurnick. Not only is a mini-tightrope exceedingly difficult for an MPJ, if the underlying boney deformity is not addressed, it will do nothing for the long-term outcome. The 2nd and 3rd metatarsals are both elongated and medially angulated in this patient, causing the lateral deviation of the toes. Correctional osteotomies of the second/third metatarsal are necessary. This can be done distally with a translational Weil.


 


Although the metatarsal head may end up appearing laterally angulated to achieve the correction necessary, the digit will maintain it's position in the transverse position, and weight-bearing may be initiated sooner than with a proximal osteotomy.


 


Ben Cullen, DPM, San Diego, CA

09/08/2020    

RESPONSES/COMMENTS (NON-CLINICAL) - PART 2B



From: Richard A. Simmons, DPM


 



Dr. Ricketti asks why more podiatrists are not using the Phenol EZ Swabs for P&As. I rarely do P&As anymore since my practice consists primarily of terminal hospice patients. Initially, it looks like the EZ Swabs are expensive; however, here’s another twist. Over the past few years, when I attended risk management lectures, the attorneys who have spoken tell us about the need for everything in the office to have an expiration date on it and to remove everything from the office whose expiration date has come and gone. If I remember the lecture correctly, once any bottle is opened, it immediately has an expiration date of 30-days.


 


If OSHA shows up at your office at 8 a.m., by law, they have to be allowed access. Attorneys are now representing physicians facing tens of thousands of dollars of fines for unmarked/non-dated products (injectables, creams, lotions, etc.) that are commonly used. So, if you have a disgruntled employee who you recently fired, they can get money by being a whistle-blower. The last lecture I heard about this was put on by the Academy of Continuing Podiatric Medical Education, August 29, 2019.


 


Richard A. Simmons, DPM, Rockledge, FL


08/13/2020    

RESPONSES/COMMENTS (NON-CLINICAL) - PART 2B



From: Christian A. Robertozzi, DPM


 



The posts on hospital privileging have valid points on both sides. There is a perspective that has been touched upon but its authority and influence are not being fully appreciated. That is the viewpoint from each hospital’s credentials committee. The purpose of the committee’s existence is to make sure that physicians get privileges only for what they are capable of doing.


 


For the last 3 years, I have sat on my hospital’s credentials committee (Newton Medical Center, Atlantic Health System). The hospital as well as the entire system are Joint Commission approved facilities. In order to maintain Joint Commission approval, the hospital must follow the protocols as set out by the Joint Commission. Each hospital has the right to decide who can have privileges and what...


 


Editor's Note: Dr. Robertozzi's extended-length letter can be read here


08/05/2020    

RESPONSES/COMMENTS (NON-CLINICAL) - PART 2B


RE: DEA Registration Fees to Rise (Richard Rettig, DPM)


From: Joel Lang, DPM


 


In the final analysis, the registration costs less than a dollar a day. Isn't it worth it to have the flexibility to prescribe narcotics when indicated, rather than to explain to a patient that you don't have the necessary DEA registration? It diminishes your standing for the patient who will wonder why you don't have what all his/her other doctors have. Additionally, the cost is such a small percentage of gross/net as to be inconsequential.


 


How many years did the profession fight to get the right to prescribe narcotics? When I graduated from the New York college, that option was not even available. Narcotic prescribing was not even part of the curriculum.


 


Joel Lang, DPM, (retired) Cheverly, MD 

07/30/2020    

RESPONSES/COMMENTS (NON-CLINICAL) - PART 2B



From:  Brian Kiel, DPM


 


Dr. Secord is absolutely correct that this is not really sclerosing. The term is used by podiatrists to describe the injection of 4% alcohol/local anesthetic. We bill this as a CPT 64455, injection of a local anesthetic. I do think this procedure is very effective but it is not sclerosing; the term differentiates this for clinical diagnosis of a neuroma.


 


Brian Kiel, DPM, Memphis, TN

07/28/2020    

RESPONSES/COMMENTS (NON-CLINICAL) - PART 2B



From: Anthony Hoffman, DPM


 



I have a couple of scenarios in which I like the ability to offer the series of 4% alcohol sclerotherapy injections. The first scenario is for injection of a nerve other than a Morton's neuroma (it happens to be a branch of the lateral calcaneal nerve around the lateral wall of the calcaneus) where there is no need to do a decompression in that there is no entrapment of the nerve. The other scenario is a patient who is not a surgical candidate for various reasons. Having 4% alcohol in our treatment armamentarium is beneficial. By the way, FFF enterprises charges $11,000 for 10 vials (and they will not send only 1 or 2; you have to purchase 10.)


 


Anthony Hoffman, DPM, Oakland, CA


07/23/2020    

RESPONSES/COMMENTS (NON-CLINICAL) - PART 2B



From: Elliot Udell, DPM


 



Dr. Roth asks a good question when he questions why certain companies are charging so much money for sclerosing alcohol. He should also ask why the cost of masks and gloves have skyrocketed in price. I took a deep breath when I called a supplier yesterday to re-order disposable masks and was told that the price went from $5.95 a box to $35 a box. Gloves also went up 20%. The question is whether this is allowable supply and demand or are these examples of companies ripping off consumers. If it’s the latter, especially during the pandemic, government agencies need to look into this, and we as consumers need to make these agencies aware of what is happening. 


 


Elliot Udell, DPM, HIcksville, NY 


06/25/2020    

RESPONSES/COMMENTS (NON-CLINICAL) - PART 2B



From: Dennis Shavelson, DPM


 


In changing our focus and training towards surgery, as a profession, we are forced to become more and more vestigial regarding closed-chain lower extremity biomechanics. In medicine, a surgeon’s card reads that he/she is a surgical specialist. A physiatrist's card reads rehabilitation specialist, and a dermatologist's reads skin specialist, etc. They can and do consult outside of their specialty at a lesser level, but remain dedicated to one or more specialties. They consult with other specialists when their training and experience falls short of the problem at hand by putting the patient in the hands more expert than their own.


 


I can count the number of biomechanical consultations that I have received from surgeons in my 40+ years of podiatry on nine or ten fingers. Instead, I have fostered relationships where I can confidently refer the few surgical cases I am asked to consult on and in return, I am called upon to assist them biomechanically pre- and post-op. In summary, in becoming podiatric foot and ankle surgeons, we are practicing a stunted version of biomechanics and orthotics without incentivizing non-surgical podiatric consultants in integrative biomechanics, making DPMs like me more and more vestigial.


 


Dennis Shavelson, DPM, NY, NY

06/11/2020    

RESPONSES/COMMENTS (NON-CLINICAL) - PART 2B



From: Elliot Udell, DPM


 


Thank you Dr. Markinson for once again reminding us of the non-COVID-19 risks associated with grinding toenails. Several responders have legitimately asked how to adequately soften nails so as to properly debride them without the use of an electrical drill. 


 


As an allergy sufferer, I had to limit nail grinding very early in my career. I coughed and wheezed, even with the use of dust extractors. When papers came out showing that breathing in nail dust was an occupational hazard, I took all of the drills and extractors to the nearest dumpster. Some papers showed that the dust remains in the air for over 11 hours. 


 


There are ways to soften nails so that they can be adequately debrided. Spraying the nails with "Three Way Solution", often works. Another way is to dispense some of the nail softening products and insist that the patients use them daily between visits. We get great results with Bako's 40% urea nail gel as well as other products such as Formula 7. We have found that if the patients use these as well as other urea containing nail products, there is no need to mourn the use of nail grinding devices. 


 


Elliot Udell, DPM, Hicksville, NY

05/25/2020    

RESPONSES/COMMENTS (NON-CLINICAL) - PART 2B



 


I purchased the Swift immunotherapy device in August of 2019. I found that I had a significant amount of patients, both adult and pediatric, with lesions that often times were referred from dermatologists and colleagues specifically for CO2 laser excision after failing various conservative treatments. I had a 16-year-old patient scheduled for CO2 laser excision in September of 2019. I called his parents after purchasing the device and recommended that we try the Swift procedure before CO2 laser excision. After three treatments, all of the patient’s lesions (greater than 30 on both feet) resolved.


 


The Swift device can cause discomfort. This discomfort is far less than surgical excision. I find it is extremely helpful to prescribe EMLA cream and apply this for 5 to 8 minutes prior to Swift treatment. Patients feel discomfort/pain in the form of heat. Once the treatment is over, the discomfort dissipates. The patient can exercise or go about their activities of daily living immediately post treatment without any discomfort.


 


The device is very easy to use. It is extremely effective in pediatric patients with young, healthy immune systems. I often find that lesions are completely resolved after 3 to 4 treatments. In adult patients, with older immune systems, often times they need between four and six treatments.


 


Disclosure: I recently became a consultant for the Swift device company.


 


Rachel Balloch, DPM, Avon, CT

05/22/2020    

RESPONSES/COMMENTS (NON-CLINICAL) - PART 2B



From: Alec Hochstein, DPM


 



I like to consider myself a progressive podiatrist. I try to add something to my practice at least yearly that brings a certain polish and a new technology to the office. This past year after seeing the initial advertisements for the Swift Emblation unit, I just couldn’t resist bringing it into my office, as I find verrucae to be extremely frustrating entities to treat (as I’m sure many podiatrists and dermatologists do as well).


 


I could not be happier with my decision to add this to my treatment armamentarium as the results and adoption by my patients have been nothing short of miraculous. I have no problem stating that my resolution rates for my verruca treatments with Swift Emblation is over 90%. The treatment is extremely well tolerated by my patients. It has been a great addition to the office. 


 


Disclosure: I am a consultant for Saorsa North American distributors of Swift. 


 


Alec Hochstein, DPM, Great Neck, NY


03/04/2020    

RESPONSES/COMMENTS (NON-CLINICAL) - PART 2B



From: Elliot Udell, DPM


 



Not every nurse practitioner is trained in treating from the ankle down. The same applies to MDs and DOs. When managed care first began, insurance companies put tremendous pressure on primary care doctors not to send patients to specialists, or risk being docked in some way. A patient finally was referred to me by a very good internist in my area. He had been treating her for over six months for tinea pedis to no avail. He finally used his better judgment and sent the patient for a podiatry consult. I had to diplomatically explain to the patient that the reason why her internist's treatment did not cure her foot problem was that even the best of antifungals do not have any effect on interdigital hyperkeratoses.


 


Elliot Udell, DPM, Hicksville, NY


02/03/2020    

RESPONSES/COMMENTS (NON-CLINICAL) - PART 2B



From: Stephen Kominsky, DPM


 



The last few words spoken by [Dr. Jacobs'] patient have been my mantra for the 37 years that I have been in practice. Instead of the APMA producing Johnny Sorefoot Balloons and the like, I have always felt, and feel even stronger today, that it is an absolute MUST that the “lay-public” be educated about what a podiatrist can do. For someone in this day and age to ask a podiatrist that question is a "Shonda" (Yiddish expression meaning something terrible).


 


Just like the AMA has done a miserable job on educating the public about the declining reimbursement, we have done a poor job regarding our education and abilities. We MUST be better at telling everyone what a podiatrist can do, and do it better than anyone else, or we will not survive. 


 


Stephen Kominsky, DPM, Washington, DC


01/31/2020    

RESPONSES/COMMENTS (NON-CLINICAL) - PART 2B



From: Allen Jacobs, DPM


 


“Although lasers are approved by the FDA for onychomycosis” is not entirely correct. The FDA states that lasers may be used as adjunct therapy to supplement accepted management protocols for the treatment of onychomycosis. In fact, the FDA published policy on the matter advises not to claim that lasers are a cure for onychomycosis, but provide only temporary improvement in the appearance of the toenail. At-risk populations in which the treatment of onychomycosis is considered necessary (e.g.- diabetics, PAD patients, immunosuppressed patients) are denied appropriate treatment when lasers are employed, while subjected to potential risks.


 


The FDA approved the safety of lasers, not the specific employment of this modality for onychomycosis. And yes, while speciation is not required as lasers are not “species specific," some confirmation of fungal infection would seem appropriate prior to treatment.


 


I was evaluating a post-op Austin-Akin patient today. She told me that she watched the show. Her exact words were; “I’m impressed. I had no idea podiatrists did such complicated things.” 


 


Allen Jacobs, DPM, St. Louis, MO

11/01/2019    

RESPONSES/COMMENTS (NON-CLINICAL) - PART 2B



From: Robert Kornfeld, DPM


 



This discussion is a critically important one, especially because my professional path brought me to a deep understanding of human physiology, the foundations for health and healing, and a never-ending focus on understanding mechanisms of pathology BEFORE symptoms are treated. I pursued a path in functional medicine for foot and ankle pathology because it provides a means to heal pedal pathology AND improve the health of the patient. This has been my path and my passion since 1987 (I am a 1980 graduate of NYCPM). My career has been extraordinarily satisfying because the healing is in medicine, not surgery. Of course there’s a place for surgery, but without a true mechanistic approach to healing, we correct one issue but leave our patients open to future pathology.


 


Podiatry has always struggled with itself. In our zeal to be accepted as ”real doctors”, we focused on pushing ourselves into hospital operating rooms. Unfortunately, that...


 


Editor's note: Dr. Kornfeld's extended-length letter can be read here.


10/26/2019    

RESPONSES/COMMENTS (NON-CLINICAL) - PART 2B



From: Jon Purdy, DPM


 


There is no need to compare dentistry to podiatry in this debate. Dentists are not defined as physicians nor do they have any competition among the medical community. Our closest colleague and competitor, orthopedics, has gone through its own transitions over the years. Originally a specialty in addressing pediatric deformities (the Greek derivation meaning “straight babies”) has transitioned to anything bone related in all age groups.


 


I find it a difficult argument to claim three years of residency isn’t a sufficient amount of time to learn the surgical and medical conditions related to the lower extremity. Orthopedics learns the surgical and medically related treatments of the entire body in four years. The first of five years concentrates on general surgery and medicine. Once an orthopedist’s standardized residency is completed, they may choose to do additional training in specialized areas or concentrate their practice on specific areas of their basic training.


 


Change is inevitable and our profession has not kept up. It should be obvious at this point, an MD degree will be our only acceptance into the medical world, fair or not. Aside from that, not having standardized training in ALL aspects of lower extremity care, and one single certifying board, is foolish, to say the least.


 


Jon Purdy, DPM, New Iberia, LA

09/19/2019    

RESPONSES/COMMENTS (NON-CLINICAL) - PART 2B



From: Jeffrey Root


 



Dr. Udell states he has no idea why orthotic labs stopped sponsoring biomechanics at conferences and podiatry schools. As the owner of a prescription foot orthotic laboratory I can shed some light on the subject. The short answer is that there is no/inadequate return on investment. Sponsorships are essentially a marketing expense for most businesses. If an orthotic lab can’t benefit from a sponsorship or if it can’t afford to fund one for altruistic purposes, then they are unlikely to do so.


 


The economics of the custom foot orthotic manufacturing industry have changed over the years. There was a time when the exhibit halls at podiatry conferences had many foot orthotic labs in attendance. That is no longer the case. In fact, exhibitors at podiatry conferences are down in general. It's extremely expensive to exhibit, sponsor speakers, or to otherwise financially support educational content. As Dr. Richie indicated, foot orthotic labs have relatively meager budgets and have watched their profit margins shrink for many years, in part, because podiatry has become more of a surgical specialty. Unless that trend changes, you are not likely to see orthotic labs support biomechanics like they once did.


 


Jeffrey Root, President, Root Laboratory, Inc.


09/18/2019    

RESPONSES/COMMENTS (NON-CLINICAL) - PART 2B



From: Elliot Udell, DPM


 



Doug, in an ideal world, corporate entities would have no say in what is presented at medical conferences. We do not live in an ideal world. When I lecture at podiatry conferences, I don't always get paid and I have sometimes paid for my own room, board, and transportation, and given multiple lectures. Why do I do this? To be of service to my profession and the public it serves. There are others like me.


 


Unfortunately, this model is not sustainable even for me. Many conferences including ones that I have chaired cannot afford to subsidize all of its speakers or depend on all of its speakers to lecture for gratis. Hence, they have to turn to the corporate world for help or scrap the seminar. As for podiatry labs, when I started practice back in the 70's, Langer labs, Schuster labs, and other labs did sponsor biomechanics at conferences and at the schools. Why did they stop? I have no idea. 


 


Elliot Udell, DPM, Hicksville, NY 


07/05/2019    

RESPONSES/COMMENTS (NON-CLINICAL) - PART 2B



From: Andrew Levy, DPM 


 


I feel a need to add another voice of support to Doctor DeHeer's concerns and important consideration for finding ways to prevent suicide among our residents and our peers. We too have suffered the sadness of this tragedy in our community, in our professional ranks, and with our professional colleagues in other fields. I discussed this today with a patient who is director of a post-doc program in our community, and they also have that problem as well. This is, unfortunately, ubiquitous to all of our societies. 


 


While we search for the appropriate tools to study the phenomenon and assess different tools to help fight the problems through mentorship, referral to physician services, or the importance of enlightening our fellow colleagues, the important work must...


 


Editor's note: Dr. Levy's extended-length letter can be read here.

07/04/2019    

RESPONSES/COMMENTS (NON-CLINICAL) - PART 2B



From: Robert Scott Steinberg, DPM, Irwin B. Malament, DPM


 



Dr. Bellezza's comments underscore the need for all the colleges of podiatric medicine to immediately add a full year course on mental health (psychology/psychiatry). So far, the Scholl College of Podiatric Medicine has refused. The Illinois Podiatric Medical Association has reported they have had multiple meetings with the college, and all the college does is kick-the-can-down-the-road.  


 


Robert Scott Steinberg, DPM, Schaumburg, IL


 


I applaud Dr. Deheer's survey regarding suicide prevention in podiatric residents. This should be extended to all physicians in practice as well. I recently lost a good friend and former class-mate who committed suicide last week. We talked 4 days before he did this and never attempted to reach out that there was a problem I could help him with or talk about.


 


We are all under a lot of stress these days with practice and family. A lot of issues are under the surface and if we are proactive, possibly we could avoid these tragedies.


 


Irwin B. Malament, DPM, Indianapolis, IN


07/03/2019    

RESPONSES/COMMENTS (NON-CLINICAL) - PART 2B



From: Larissa Paulovich, DPM


 


Dr. Bellezza’s lamentable letter implies that the stressors of our training programs are the only reason why a resident would commit suicide, and ignores that 1 in 12 Americans suffer from depression and 18% from anxiety.


 


So your opinion is that a resident “suck it up” and ignore their depression because they want to appear “tough” or don’t want to be stigmatized since it’s “just podiatry”. But I’d like you to combine that feeling with the following scenario: A “lowly DPM resident” is overworked because their senior residents “already took all that call as first years” so they’re now on call for 38 days straight; they’re also feeling pressure from their spouse for not being around; in the back of their mind they’ve had to put off the $200,000 student loan bill at 6.8% interest yearly because... 


 


Editor's note: Dr. Paulovich's extended-length letter can be read here.

06/26/2019    

RESPONSES/COMMENTS (NON-CLINICAL) - PART 2B



From: George Jacobson, DPM


 



The active ingredient in Control III is benzyl ammonium chloride, so it is the same active ingredient as in Benz-All. I haven't heard anyone mention the use of ultrasonic units to assist with removal of any debris and other benefits. A hot bead sterilizer also is beneficial. Both of those steps prior to placing instruments in cold disinfectant have worked well for 30+ years. I applaud those who have the staff and system in place to autoclave all instruments all day long. 


 


In a small solo practice, it’s hard to implement. I do believe if we saw a deleterious effect to a patient, based on instrument care, we would change our office procedures. It's an individual choice based on the clinical experiences within our own facilities. Instrument care and practices and procedures may be better or worse from facility to facility. Patients often comment on our cleanliness versus that of other doctors’ offices. We should not embolden trial attorneys with only one acceptable methodology.


 


George Jacobson, DPM, Hollywood, FL


04/23/2019    

RESPONSES/COMMENTS (NON-CLINICAL) - PART 2B



From: Paul M Taylor, DPM


 



Maryland offers an inactive status license. For $50 a year, if I ever decide to resume practice, I would need to update all my CMEs. If I did not renew my license at all, if I needed to go back into practice, I would need to re-apply, including taking the national boards. Although I do not intend to resume practice, paying the $50 a year is a nice insurance policy in case my situation changes.


 


Paul M Taylor, DPM, Silver Spring, MD


01/31/2019    

RESPONSES/COMMENTS (NON-CLINICAL) - PART 2B



From: Dan Klein, DPM


 



When will podiatrists realize that having a DPM license will never allow you the privileges of your counterparts in the MD/DO arena. It doesn’t matter how many courses or certifications of training in marijuana dispensing you take, at the end of the day, you are still a podiatrist. I have advocated and others have advocated for getting a dual license DPM and MD/DO license. Until the schools offer an avenue to obtain these licenses, podiatrists need to recognize their limitations. MD/DOs rule the land! Final word. 


 


Dan Klein, DPM, Fort Smith, AR


01/30/2019    

RESPONSES/COMMENTS (NON-CLINICAL) - PART 2B



From: Dia McCaughan, DPM


 



I actually took the 4-hour certification course for this at my local hospital, for a fee. Afterward, I logged onto the PA Department of Health and the medical cannabis website to register my practice with the Commonwealth. It was then that I discovered I was not permitted to register since I was not an MD/DO.  


 


I comprised a thorough letter to my local representative, who is now the Speaker of the House of PA, discussing the issue why podiatry should be included and the qualifying conditions we manage on a daily basis. He responded immediately, agreeing with me, and stated he would look into it. Three weeks later, I received a call from the PA Department of Health, letting me know podiatrists cannot register at this time, and no expected approval date has been set. So, back to square one again, I suppose. 


 


Dia McCaughan, DPM, New Providence, PA

GSource


Our privacy policy has changed.
Click HERE to read it!